IGHE and neoplasm: This and other immune signatures normally deployed in infection clearance may potentially be enhanced by specific immunotherapy approaches such as a tumor-specific IgE or by attenuated parasite vaccines,50,51 to reverse immunosuppression and confer therapeutic benefits in ovarian and other cancers.